Health News

Project Dulce: Made for Your Community
Mexican Americans are more likely than whites to develop type 2 diabetes. Once they have diabetes, Mexican Americans also face a greater risk for certain complications. How can this gap be closed?
Cholesterol-lowering Drugs May Treat Brain Cancer
One of the most exciting frontiers in oncology is discovering molecular behavior that responds to existing drug therapies. Just such a discovery has been made regarding a deadly form of brain cancer.
Stents Help the Medicine Go Down
Patients who have previously suffered from a blood vessel blockage and received a medication-coated stent to prop the artery open may have a lower risk of developing another blockage or having a heart attack.
"I Will Survive"
Many cancer survivors report having pain and tiredness after cancer treatment and recovering, but why are these rates so high? Researchers examined the reason for these problems.
Different Personalities Are Not So Different
Family history has been a known risk factor for mental illnesses like schizophrenia and bipolar disorder. Now, researchers find more similarity between these disorders.
Optimism, Self-Esteem and a Feeling of Mastery?
A long-standing debate in the psychological community is whether traits such as self-esteem, optimism and mastery - the belief that you have control over your own life - are genetically imbedded or developed throughout life.
Hearing the Music Loud and Clear
It may go against what your parents always warned you about, but lifelong musicians actually experience less hearing loss as they age.
New OCD Treatment on Horizon
A new model of the symptoms of obsessive-compulsive disorder (OCD), as well as its treatment, has been created. The model offers new insight into the disorder, which disrupts a person's life with unwanted thoughts and repetitive rituals that cause anxiety.
Telestroke on Tap for Rural Locales
For some small, rural hospitals, having an around-the-clock stroke expert on staff isn't cost effective as compared to the number of strokes treated. Instead a technological solution called telestroke may be more appropriate.
FDA Approves Prolia for osteoporosis
On September 16, 2011, the U.S. Food and Drug Administration granted approval for denosumab ( Prolia , Amgen Inc.) as a treatment to increase bone mass in patients at high risk for fracture receiving androgen deprivation therapy (ADT) for nonmetastatic prostate cancer or adjuvant aromatase inhibitor (AI) therapy for breast cancer. In men with nonmetastatic prostate cancer, denosumab also reduced the incidence of vertebral fracture.
<< first142214231424142514261427142814291430last >>

REFINE